These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24256012)

  • 1. Acquired haemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribarivin: role of rituximab.
    Fernández de Palencia Espinosa MÁ; Arocas Casañ V; Garrido Corro B; de la Rubia Nieto A
    Farm Hosp; 2013; 37(6):494-8. PubMed ID: 24256012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acquired hemophilia A in a patient with chronic hepatitis C virus infection receiving treatment with peginterferon α-2a].
    Martínez Pascual C; Antón Ródenas G; Ortiz Sánchez ML; Pons Miñano JA
    Med Clin (Barc); 2013 Sep; 141(5):228-9. PubMed ID: 23473306
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired haemophilia complicated with gastrointestinal bleeding and spontaneous iliopsoas muscle haematoma in a woman with chronic C hepatitis under treatment with pegylated IFN alpha 2a and ribavirin.
    Boţianu AM; Demian S; Macarie I; Georgescu D; Oltean G; Băţagă S
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):93-5. PubMed ID: 22457865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin.
    Campos-de-Magalhães M; Eduardo Brandão-Mello C; Lúcia Elias Pires M; Cecília da Fonseca Salgado M; Barcelo de Brito S; José de Almeida A
    Hematology; 2011 Mar; 16(2):80-5. PubMed ID: 21418737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L11. Hepatitis C virus mixed cryoglobulinemia vasculitis: therapeutic options.
    Cacoub P; Terrier B; Saadoun D
    Presse Med; 2013 Apr; 42(4 Pt 2):523-7. PubMed ID: 23453499
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.
    Liu CH; Huang CF; Liu CJ; Dai CY; Liang CC; Huang JF; Hung PH; Tsai HB; Tsai MK; Chen SI; Lin JW; Yang SS; Su TH; Yang HC; Chen PJ; Chen DS; Chuang WL; Yu ML; Kao JH
    Ann Intern Med; 2013 Dec; 159(11):729-38. PubMed ID: 24297189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term response to rituximab in a patient with acquired hemophilia].
    García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
    Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients.
    Terrier B; Saadoun D; Sène D; Sellam J; Pérard L; Coppéré B; Karras A; Blanc F; Buchler M; Plaisier E; Ghillani P; Rosenzwajg M; Cacoub P
    Arthritis Rheum; 2009 Aug; 60(8):2531-40. PubMed ID: 19644879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab combined with Peg-interferon-ribavirin in refractory hepatitis C virus-associated cryoglobulinaemia vasculitis.
    Saadoun D; Resche-Rigon M; Sene D; Perard L; Karras A; Cacoub P
    Ann Rheum Dis; 2008 Oct; 67(10):1431-6. PubMed ID: 18178690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon (alone or with ribavirin) for chronic hepatitis C in haemodialysis population.
    Espinosa M; Hernàndez J; Arenas MD; Carnicer F; Caramelo C; Fabrizi F
    Kidney Blood Press Res; 2015; 40(3):258-65. PubMed ID: 25997572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
    Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
    Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
    Chung RT; Andersen J; Volberding P; Robbins GK; Liu T; Sherman KE; Peters MG; Koziel MJ; Bhan AK; Alston B; Colquhoun D; Nevin T; Harb G; van der Horst C;
    N Engl J Med; 2004 Jul; 351(5):451-9. PubMed ID: 15282352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis complicating treatment of hepatitis C in an HIV-infected haemophilia A patient.
    Killingley B; Bhagani S; Slapak G; Yee TT; Johnson M
    Haemophilia; 2006 Sep; 12(5):545-7. PubMed ID: 16919087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired factor VIII inhibitor in patients with hepatitis C virus infection and the role of interferon-alpha: a case report.
    Schreiber ZA; Bräu N
    Am J Hematol; 2005 Dec; 80(4):295-8. PubMed ID: 16315253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin.
    Antonini MG; Babudieri S; Maida I; Baiguera C; Zanini B; Fenu L; Dettori G; Manno D; Mura MS; Carosi G; Puoti M
    Infection; 2008 Jun; 36(3):250-5. PubMed ID: 18458815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
    Fried MW; Shiffman ML; Reddy KR; Smith C; Marinos G; Gonçales FL; Häussinger D; Diago M; Carosi G; Dhumeaux D; Craxi A; Lin A; Hoffman J; Yu J
    N Engl J Med; 2002 Sep; 347(13):975-82. PubMed ID: 12324553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and severity of infections according to the development of neutropenia during combined therapy with pegylated interferon-alpha2a plus ribavirin in chronic hepatitis C infection.
    Juarez-Navarro A; Vera-de-León L; Navarro JM; Chirino-Sprung R; Díaz-Hernandez M; Casillas-Davila L; Dehesa-Violante M
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):317-22. PubMed ID: 16082419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celiac disease manifested during the treatment of chronic hepatitis C by pegylated alpha interferon and ribavirin.
    Gombosova L; Jarcuska P; Benova B; Benicky M; Lazurova I
    Bratisl Lek Listy; 2011; 112(6):360-2. PubMed ID: 21692415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor VIII inhibitor associated with peginterferon.
    Herman C; Boggio L; Green D
    Haemophilia; 2005 Jul; 11(4):408-10. PubMed ID: 16011596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.